Jenny Jarboe, MBA Deloitte Life Sciences Strategy and Analytics
Jenny Jarboe is a senior manager for Deloitte Consulting’s Life Sciences Strategy and Analytics practice. She has over 15 years of life sciences experience, spanning various industries, including public sector government innovation, non-profit delivery and life sciences strategy. Today, her work primarily addresses barriers to care, including developing affordable programs for innovative therapies to support patient and employee access. She recently supported a global major biopharma organization in designing and implementing a novel risk pool model for cell and gene therapy that would allow employers to pool resources to address ‘lightning strike’ claims – insulating employers from the cost of significant health events and ensuring employees can access life-saving products.
Jenny received her undergraduate degree in biochemistry and molecular biology from the University of Richmond. She earned her Master of Business Administration from The Wharton School. For more information on her work on novel Cell and Gene Therapy affordability models, you can read a paper she co-authored here: Gene Therapy Pricing Innovation.